DNA damage generated by transcription-replication conflicts explains the synthetic lethality of PARP inhibitors with homologous recombination deficiency

被引：0
|
作者：
Halazonetis, Thanos D.
Petropoulos, Michalis
Rossetti, Giacomo G.
Karamichali, Angeliki
Freudenmann, Alena
Iacovino, Luca
Dionellis, Vasilis
Sotiriou, Sotirios K.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-1566
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1566
引用
收藏
页数：2
相关论文
共 20 条
  • [1] Synthetic lethality by PARP inhibitors: new mechanism uncovered based on unresolved transcription-replication conflicts
    Kolesnichenko, Marina
    Scheidereit, Claus
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [2] Transcription-replication conflicts underlie sensitivity to PARP inhibitors
    Petropoulos, Michalis
    Karamichali, Angeliki
    Rossetti, Giacomo G.
    Freudenmann, Alena
    Iacovino, Luca G.
    Dionellis, Vasilis S.
    Sotiriou, Sotirios K.
    Halazonetis, Thanos D.
    NATURE, 2024, 628 (8007) : 433 - +
  • [3] New Targeted Agents in Gynecologic Cancers: Synthetic Lethality, Homologous Recombination Deficiency, and PARP Inhibitors
    Liu, Fong W.
    Tewari, Krishnansu S.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2016, 17 (03)
  • [4] New Targeted Agents in Gynecologic Cancers: Synthetic Lethality, Homologous Recombination Deficiency, and PARP Inhibitors
    Fong W. Liu
    Krishnansu S. Tewari
    Current Treatment Options in Oncology, 2016, 17
  • [5] ATR, CHK1 and WEE1 inhibitors cause homologous recombination repair deficiency to induce synthetic lethality with PARP inhibitors
    Smith, Hannah L.
    Willmore, Elaine
    Prendergast, Lisa
    Curtin, Nicola J.
    BRITISH JOURNAL OF CANCER, 2024, 131 (05) : 905 - 917
  • [6] Biliary tract cancer and genomic alterations in homologous recombinant deficiency: exploiting synthetic lethality with PARP inhibitors
    Ahn, Daniel H.
    Bekaii-Saab, Tanios
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (01)
  • [7] BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombination Deficiency
    Sun, Chaoyang
    Yin, Jun
    Fang, Yong
    Chen, Jian
    Jeong, Kang Jin
    Chen, Xiaohua
    Vellano, Christopher P.
    Ju, Zhenlin
    Zhao, Wei
    Zhang, Dong
    Lu, Yiling
    Meric-Bernstam, Funda
    Yap, Timothy A.
    Hattersley, Maureen
    O'Connor, Mark J.
    Chen, Huawei
    Fawell, Stephen
    Lin, Shiaw-Yih
    Peng, Guang
    Mills, Gordon B.
    CANCER CELL, 2018, 33 (03) : 401 - +
  • [8] CDK12 loss drives prostate cancer progression, transcription-replication conflicts, and synthetic lethality with paralog CDK13
    Tien, Jean Ching-Yi
    Luo, Jie
    Chang, Yu
    Zhang, Yuping
    Cheng, Yunhui
    Wang, Xiaoju
    Yang, Jianzhang
    Mannan, Rahul
    Mahapatra, Somnath
    Shah, Palak
    Wang, Xiao-Ming
    Todd, Abigail J.
    Eyunni, Sanjana
    Cheng, Caleb
    Rebernick, Ryan J.
    Xiao, Lanbo
    Bao, Yi
    Neiswender, James
    Brough, Rachel
    Pettitt, Stephen J.
    Cao, Xuhong
    Miner, Stephanie J.
    Zhou, Licheng
    Wu, Yi-Mi
    Labanca, Estefania
    Wang, Yuzhuo
    Parolia, Abhijit
    Cieslik, Marcin
    Robinson, Dan R.
    Wang, Zhen
    Feng, Felix Y.
    Chou, Jonathan
    Lord, Christopher J.
    Ding, Ke
    Chinnaiyan, Arul M.
    CELL REPORTS MEDICINE, 2024, 5 (10)
  • [9] DNA topoisomerase-mediated transcription-replication conflicts cause DNA damage by a transient increase of R loops and proteasome activity
    Marinello, Jessica
    Delcuratolo, Maria
    Pommier, Yves
    Binaschi, Monica
    Pellacani, Andrea
    Capranico, Giovanni
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [10] Fance deficiency inhibits primordial germ cell proliferation associated with transcription-replication conflicts accumulate and DNA repair defects
    Zhou, Zhixian
    Yin, Huan
    Suye, Suye
    Ren, Zhen
    Yan, Lei
    Shi, Liye
    Fu, Chun
    JOURNAL OF OVARIAN RESEARCH, 2023, 16 (01)
12